Static Chart Recursion Pharmaceuticals, Inc.
Equities
RXRX
US75629V1044
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.910 USD | +2.22% | +7.13% | -29.92% |
09-03 | Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating | MT |
09-03 | Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends | MT |
MarketScreener is also available in this country: United States.
Switch edition